• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Erstveröffentlichung
2014
Authors
Döhner, Hartmut
Luebbert, Michael
Fiedler, Walter
Fouillard, Loic
Haaland, Alf
et al.
Wissenschaftlicher Artikel


Published in
Blood ; 124 (2014), 9. - S. 1426-1433. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood-2014-03-560557
Institutions
UKU. Klinik für Innere Medizin III
Subject headings
[Free subject headings]: acute myeloid-leukemia | polo-like kinase | inhibits tumor-growth | advanced solid tumors | antitumor-activity | elderly-patients | cancer-therapy | older patients | open-label | selective inhibitor
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement